A large body of evidence emerging from pharmacological and knockout studies suggests the involvement of the delta opioid peptide (DOP) receptor in the control of anxiety and depression.
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist
CALO', Girolamo
2006
Abstract
A large body of evidence emerging from pharmacological and knockout studies suggests the involvement of the delta opioid peptide (DOP) receptor in the control of anxiety and depression.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
